Breaking News
August 16, 2018 - Does medical school take too long?
August 16, 2018 - Brown University researchers reveal key physical properties of ‘giant’ cancer cells
August 16, 2018 - Regular resistance training improves exercise motivation
August 16, 2018 - Feds urge states to encourage cheaper plans off the exchanges
August 16, 2018 - Seven activities that prevent you from getting quality sleep during summer
August 16, 2018 - Five ways to tell if your baby is getting enough milk from breastfeeding
August 16, 2018 - From Pigs to Peacocks, What’s Up With Those ‘Emotional-Support Animals’?
August 16, 2018 - Breast cancers enlist the help of normal cells to help them spread and survive
August 16, 2018 - Engaging with “high-need” patients outside the clinic
August 16, 2018 - Research illuminates how online forum may offer suicide prevention support for males
August 16, 2018 - Researchers identify way to grow immune cells at large scale for preventing cancer reoccurrence
August 15, 2018 - Keck Medicine of USC’s hospitals ranked among nation’s best for the 10th consecutive year
August 15, 2018 - Researchers compare existing approaches for automating diagnostic procedures of skin lesions
August 15, 2018 - Autism risk determined by health of mom’s gut, research reveals
August 15, 2018 - WELL for Life challenges you to explore the great outdoors
August 15, 2018 - ‘Zombie’ gene protects elephants from cancer, study finds
August 15, 2018 - Ebola outbreak in Congo spreads to active combat zone
August 15, 2018 - Study highlights pollution exposure of babies in prams
August 15, 2018 - Study provides insight into link between sleep apnea and lipid metabolism
August 15, 2018 - New study focuses on promise of gene therapy for Amish nemaline myopathy
August 15, 2018 - Researchers discover new approach to alleviate chronic itch
August 15, 2018 - Uncovering the Mysteries of MS: Medical Imaging Helps NIH Researchers Understand the Tricky Disease
August 15, 2018 - Autistic people at greater risk of becoming homeless – new research
August 15, 2018 - New imaging technique can spot tuberculosis infection in an hour
August 15, 2018 - Scientists study effects of eating breakfast versus fasting overnight before exercise
August 15, 2018 - Talking with children about suicide could save lives
August 15, 2018 - Grip strength of children predicts future cardiometabolic health
August 15, 2018 - Innovative oncofertility program launched by RMA of New York and Mount Sinai Health System
August 15, 2018 - Study shows efficacy, safety of AAV5-based gene therapy to treat sheep model of achromatopsia
August 15, 2018 - Simple score helps predict which hospitalized heart attack patients are at high risk of readmissions
August 15, 2018 - New discoveries show how protein droplets do more than keep cells’ interiors tidy
August 15, 2018 - Study shows impact of optimizing airport flight patterns on human health
August 15, 2018 - Life experiences of feeling unwanted or unplanned associated with attachment insecurity
August 15, 2018 - ACS Briefing Discusses Use of Lessons From Combat Care
August 15, 2018 - Study identifies distinct origin of ADHD in children with history of brain injury
August 15, 2018 - IgG3 antibody stops B cells from fighting pathogens in HIV patients
August 15, 2018 - Scientists discover key vulnerability of mixed lineage leukemia
August 15, 2018 - College students may experience pressures from secondary exposure to opioid abuse
August 15, 2018 - Powerful new microscope reveals inner workings of human cells with unprecedented clarity
August 15, 2018 - Married people who fight nastily more likely to suffer from leaky guts, study suggests
August 15, 2018 - Working Out After Baby – Drugs.com MedNews
August 15, 2018 - Rheumatoid Factor (RF) Test: MedlinePlus Lab Test Information
August 15, 2018 - ADHD linked to an increased risk of injury in children, study finds
August 15, 2018 - UIC researchers receive NIH funding to develop a better way to regenerate bone or tissues
August 15, 2018 - Study reveals how immune cells in the brain influence sexual behavior
August 15, 2018 - Researchers move closer to finding potential soft spot in drug-resistant tuberculosis
August 15, 2018 - Real-time dynamic monitoring of cell’s nucleus for effective cancer screening
August 15, 2018 - Lower rates of Medicare preventive care visits found in racial, ethnic minority older adults
August 15, 2018 - Scientists identify stress hormone as key factor in failure of immune system to inhibit leukemia
August 15, 2018 - Cytoplan introduces three new nutritional supplements
August 15, 2018 - Effective hemorrhage control critical for survival after motorsport accidents
August 15, 2018 - Sygnature Discovery announces ambitious expansion plan with addition of Alderley Park facility
August 15, 2018 - Dietary carbohydrates could lead to osteoarthritis, new study finds
August 15, 2018 - Male tobacco smokers have decreased number of cannabinoid CB1 receptors, study reveals
August 15, 2018 - Scientists explore ways for drug therapies to reach deadly brain tumors
August 15, 2018 - Rethinking fundamental rule of stroke care: ‘Time is brain!’
August 15, 2018 - Scientists reveal role of ‘junk DNA’ in cancer dissemination
August 15, 2018 - Google’s DeepMind AI could soon be diagnosing eye conditions
August 15, 2018 - Scientists trick the brain to embody the prosthetic limb
August 15, 2018 - Researchers focus on uncoupling obesity from diabetes
August 15, 2018 - Clinical study shows how EarlySense system effectively detects opioid-induced respiratory depression
August 15, 2018 - A class of proteins shown to be effective in reducing drug-seeking behaviors
August 15, 2018 - FundamentalVR launches first-of-its-kind SaaS software platform for surgical simulation
August 15, 2018 - Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
August 15, 2018 - Rheumatoid arthritis in pregnancy associated with low birth weight and premature birth
August 15, 2018 - Study may help increase effectiveness of antibiotics against drug-resistant bacteria
August 15, 2018 - Analyzing resident-to-resident incidents in dementia may hold the key to reducing future fatalities
August 15, 2018 - Robotic walking frame aims to help maintain mobility of older adults
August 15, 2018 - Simple intervention during routine care reduces alcohol consumption in men with HIV
August 15, 2018 - Genetics Home Reference: gout
August 15, 2018 - Scientists ID genesis of disease, focus efforts on shape-shifting tau
August 15, 2018 - OncoThira and NDSU enter into license agreement to develop, market cancer compounds
August 15, 2018 - Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma
August 15, 2018 - Common signs that indicate vision problems in children
August 15, 2018 - Removing the cancer label – overhaul in cancer classification proposed
August 15, 2018 - Prams may expose babies and toddlers to more air pollution finds study
August 15, 2018 - Duke researchers track missing T-cells in glioblastoma patients
August 15, 2018 - Cardiac Profiles Up With Exercise, Less Sitting in Early Old Age
August 15, 2018 - Precision medicine offers a glimmer of hope for Alzheimer’s disease
August 15, 2018 - Immunovia’s new blood-based testing platform accurately detects non-small cell lung cancer
Scientists seek to better protect the eye from glaucoma

Scientists seek to better protect the eye from glaucoma

image_pdfDownload PDFimage_print
Under the increased pressure of glaucoma, scientists want to help the neurons in our eyes better protect themselves and get better help from their friends.Pictured is Medical College of Georgia ophthalmologist Dr. Kathryn Bollinger. Credit: Augusta University Senior Photographer Phil Jones

Under the increased pressure of glaucoma, scientists want to help the neurons in our eyes better protect themselves and get better help from their friends.

They are working to see whether agents that activate the innate neuron protector sigma 1 receptor, or S1R, can do both.

Current glaucoma therapies work to reduce pressure in the eye by increasing outflow and/or reducing fluid production.

Dr. Kathryn Bollinger, ophthalmologist, glaucoma specialist and retinal cell biologist, has evidence that a good additional strategy would be directly enhancing protection of neurons in our eyes, called retinal ganglion cells, hopefully by directly activating S1R.

“We may be able to protect the retinal ganglion cells more long term,” says Bollinger, a faculty member in the Department of Ophthalmology at the Medical College of Georgia and James and Jean Culver Vision Discovery Institute at Augusta University and recent recipient of a $1.5 million grant from the National Eye Institute.

S1R stimulation has been shown to protect retinal ganglion cells in other disease models, but hers appears to be the first work in glaucoma, Bollinger says of the protein that is expressed in both neurons and their astrocytes throughout our visual system. Her work over the past year, funded by a mid-career physician scientist grant from the American Glaucoma Society, has focused on the impact of activating S1R in the astrocytes.

The new grant is enabling her to also look at whether activating S1R, with existing drugs already used in patients for other reasons, also enables neurons to better protect themselves.

The high pressure glaucoma produces inside the eye seems to transform astrocytes, a type of brain cell that provides nutrition and other support to the neurons, into a nemesis that instead releases toxically high levels of things like nitric oxide and reactive oxygen species.

In a rat model of glaucoma, Bollinger’s team is further exploring the impact of activating S1R with known agonists like the pain reliever pentazocine and commonly used antidepressants called selective serotonin reuptake inhibitors. They are looking at their impact on neuron survival and function and the level of support from protective proteins like brain-derived neurotrophic factor, which aids neuron survival as well as new neuron growth.

One question Bollinger and her team want to answer is how/if these drugs can protect and/or rescue neurons in the face of glaucoma.

They are looking again, in culture and their animal model, at what they suspect is S1R’s role in mediating the reactivity of astrocytes. Astrocytes’ increased reactivity, in turn, appears to prompt release of neurotoxic substances like the high levels of nitric oxide, which further raises pressure and reactivity.

But when scientists treat the usually supportive cells with S1R agonists in a dish, the cells back off their bad behavior and appear more willing to release good things like brain-derived neurotrophic factor. Bollinger notes that some astrocyte changes in response to pressure may actually be helpful to neurons while others are deleterious, which is something else she wants to understand.

“As we kind of piece together the specific consequences of astrocyte activation, we might be able to better manipulate astrocytes so they will again just protect neurons instead of damage neurons,” Bollinger says. “That is our hope.”

Her team already has good evidence that changes in astrocyte behavior occur rather quickly in response to increased pressure in the tight confines of the eyeball.

Now they also are looking at whether activating S1R increases the neurons’ own response to negatives like oxidative stress.

“We still don’t have those answers,” Bollinger says. But they have seen neurons in a dish without their astrocytes garner stress protection from S1R agonists.

“We know that S1R agonists protect retinal ganglion cells in culture. If we can understand exactly how this occurs then potentially we could come up with a more effective target for treatment,” Bollinger says.

While she hopes activating S1R works both ways to protect neurons, the bottom line that matters is that it works, Bollinger says.

Bollinger’s team has no evidence that SIR activity is decreased by glaucoma, rather she suspects the need for SIR increases with this condition.

While patients with glaucoma may experience some level of decreased vision, a minority will experience blindness, and there is no way to predict who those patients are and no additional means to intervene.

“Given our aging population and the fact that glaucoma is prevalent, we do see blindness secondary to glaucoma,” Bollinger says. Conversely, some patients may never experience any vision loss.

For the studies, the S1R agonists are injected into the abdominal cavity, but a topical application could be developed if the findings continue to hold, she adds.

Glaucoma is the second leading cause of blindness, and lost vision cannot currently be regained, according to the Glaucoma Research Foundation. Although it tends to occur in older individuals, some babies are born with glaucoma and young adults, particularly African-Americans, can have it as well.

In glaucoma, the pressure likely builds from unhealthy changes in the drainage tracts in the front of the eye that can come with aging, like reduced flexibility and increased scarring of that delicate tissue.

Lab animals with S1R deleted have slowly progressing, age- associated death of neurons in the eye similar to what happens in glaucoma.

Their efforts to rejuvenate and regenerate neurons in the eye are likely relevant as well to neurons in the brain and peripheral nervous system, Bollinger says. For example, S1R recently has been shown to have a role in amyotrophic lateral sclerosis, ALS or Lou Gehrig’s disease, which affects the nerve cells that control muscles. S1R agonists have been shown to be beneficial as well in animal models of this condition, she says.


Explore further:
Pain reliever may help relieve the vision damage of glaucoma

Provided by:
Medical College of Georgia at Augusta University

Tagged with:

About author

Related Articles